https://retacompare.com/news/roche-partners-with-rona-for-1b-rnai-obesity-drug-targeting-visceral-fat 2026-10-13T15:49:00.000Z RetatrutideCompare en 2026-10-13T15:49:00.000Z Roche Partners with Rona for $1B RNAi Obesity Drug Targeting Visceral Fat Market News, Retatrutide https://retacompare.com/news/impact-of-bariatric-surgery-on-knee-arthroplasty-outcomes 2026-10-13T00:00:00.000Z RetatrutideCompare en 2026-10-13T00:00:00.000Z Impact of Bariatric Surgery on Knee Arthroplasty Outcomes Patient Experiences, Retatrutide https://retacompare.com/news/impact-of-tirzepatide-on-heart-failure-biomarkers-reviewed 2026-10-13T00:00:00.000Z RetatrutideCompare en 2026-10-13T00:00:00.000Z Impact of Tirzepatide on Heart Failure Biomarkers Reviewed Clinical Trials, Retatrutide https://retacompare.com/news/liraglutide-induced-liver-injury-evaluated-with-rucam-case-report-insights 2026-10-13T00:00:00.000Z RetatrutideCompare en 2026-10-13T00:00:00.000Z Liraglutide-Induced Liver Injury Evaluated with RUCAM: Case Report Insights Patient Experiences, Retatrutide https://retacompare.com/news/impact-of-glp-1-agonists-on-thyroid-health-amid-rising-obesity-rates 2026-10-13T00:00:00.000Z RetatrutideCompare en 2026-10-13T00:00:00.000Z Impact of GLP-1 Agonists on Thyroid Health Amid Rising Obesity Rates Clinical Trials, Retatrutide https://retacompare.com/news/arsenic-exposure-linked-to-metabolic-disorders-across-generations 2026-10-13T00:00:00.000Z RetatrutideCompare en 2026-10-13T00:00:00.000Z Arsenic Exposure Linked to Metabolic Disorders Across Generations Clinical Trials, Retatrutide https://retacompare.com/news/retatrutide-and-glp-1-agonist-developments-in-obesity-treatment 2026-10-12T18:00:47.000Z RetatrutideCompare en 2026-10-12T18:00:47.000Z Retatrutide and GLP-1 Agonist Developments in Obesity Treatment Market News, Retatrutide https://retacompare.com/news/glp-1-drugs-prompt-food-industry-to-adjust-portions-and-products 2026-10-12T17:38:19.000Z RetatrutideCompare en 2026-10-12T17:38:19.000Z GLP-1 Drugs Prompt Food Industry to Adjust Portions and Products Market News, Retatrutide https://retacompare.com/news/neuroendocrine-role-in-appetite-regulation-for-metabolic-disorders 2026-10-12T15:17:34.055Z RetatrutideCompare en 2026-10-12T15:17:34.055Z Neuroendocrine Role in Appetite Regulation for Metabolic Disorders Clinical Trials, Retatrutide https://retacompare.com/news/lilly-faces-black-market-issues-for-obesity-drug-pre-launch 2026-10-12T14:19:44.000Z RetatrutideCompare en 2026-10-12T14:19:44.000Z Lilly Faces Black Market Issues for Obesity Drug Pre-Launch Market News, Retatrutide https://retacompare.com/news/new-weight-loss-drug-retatrutide-shows-promising-clinical-trial-results 2026-10-12T13:45:10.000Z RetatrutideCompare en 2026-10-12T13:45:10.000Z New Weight Loss Drug Retatrutide Shows Promising Clinical Trial Results Clinical Trials, Retatrutide https://retacompare.com/news/long-term-data-gaps-in-glp-1-use-for-adolescents-with-obesity 2026-10-12T13:40:32.000Z RetatrutideCompare en 2026-10-12T13:40:32.000Z Long-term Data Gaps in GLP-1 Use for Adolescents with Obesity Clinical Trials, Retatrutide https://retacompare.com/news/glp-1-therapies-show-potential-in-psoriasis-treatment 2026-10-12T13:32:00.000Z RetatrutideCompare en 2026-10-12T13:32:00.000Z GLP-1 Therapies Show Potential in Psoriasis Treatment Clinical Trials, Retatrutide https://retacompare.com/news/understanding-retatrutide-a-new-entrant-in-weight-loss-medications 2026-10-12T11:31:00.000Z RetatrutideCompare en 2026-10-12T11:31:00.000Z Understanding Retatrutide: A New Entrant in Weight-Loss Medications Weight Loss, Retatrutide https://retacompare.com/news/weight-loss-drugs-may-cause-unexpected-nail-issues 2026-10-12T09:35:18.000Z RetatrutideCompare en 2026-10-12T09:35:18.000Z Weight Loss Drugs May Cause Unexpected Nail Issues Patient Experiences, Retatrutide